Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evekeo in Pediatric ADHD Laboratory Classroom Study
NCT01986062Phase 4Completed
- Start
- Dec 2013
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of amphetamine sulfate in attention deficit hyperactivity disorder (ADHD) (2 arms). Primary endpoint: Swanson, Kotkin, Agler, M-Flynn, and Pelham Combined Score. Started Dec 2013; status: completed.
02
Drugs
amphetamine sulfate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT01986062.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01986062.